Prostate Cancer International is
for 2011 by Great NonProfits
With the conclusion of the AUA annual meeting in San Francisco and the opening of the annual meeting of ASCO in Chicago, your correspondent has once again noted some core differences in the ways the oncology community and the urology community seem to approach their research agendas.
Filed under: Living with Prostate Cancer, Management | Tagged: agenda, priority, research | 1 Comment »
Some cancer advocates have been asking for years for a clear and annual explanation of how the billions of dollars we have generated for cancer research actually gets used
Filed under: Uncategorized | Tagged: funding, investment, research, return | Comments Off
Each year the Prostate Cancer Foundation gives out its “Creativity Awards” — intended to support research into new ideas with the potential to significantly affect the diagnosis and treatment of prostate cancer.
Filed under: Drugs in development | Tagged: anti-OX40, awards, Botox, creativity, metformin, research, TKI258 | Leave a Comment »
Apparently the US House of Representatives approved the Department of Defense (DoD) appropriations bill last night before “vanishing” for their winter vacation, including (for the seventh consecutive year) $80 million for the DoD Congressionally Directed Prostate Cancer Research Program for FY2010.
Filed under: Uncategorized | Tagged: Department of Defense, initiative, program, research | Leave a Comment »
For a little over a week we have been running a poll on what patients think should be the prostate cancer research priorities for the American Urological Association’s evolving “National Urology Research Agenda.” We are now pleased to be able to offer complete results of this poll below.
Filed under: Drugs in development, Living with Prostate Cancer, Management | Tagged: priorities, research | Leave a Comment »
Over the past two weeks, I have read, watched, or listened to nearly every piece I could find on reactions to the two screening articles that appeared in the New England Journal of Medicine. I have also watched, monitored, and participated in many resulting discussions within and outside the prostate cancer community. As a consequence, [...]
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: advocacy, Diagnosis, research, risk, screening | 32 Comments »
On March 23, the following letter was sent by several members of the US House of Representatives to the acting director of the National Institutes of Health and the director of the National Cancer Institute:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: imaging, research | 5 Comments »
Several US-based prostate cancer organizations are working together to seek a major increase in funding for prostate cancer research through the Department of Defence prostate cancer research funding program for financial year 2010. If you are a US citizen affected by prostate cancer please take action on this initiative! For details, see the appropriate section [...]
Filed under: Uncategorized | Tagged: Department of Defense, funding, research | Leave a Comment »
According to a recent press release a group of more than 40 leaders from academia, industry, philanthropy, and advocacy called today for the Obama Administration, Congress, the National Institutes of Health, and the Department of Defense to increase federal funding for research into imaging technologies for less invasive and more accurate diagnosis of prostate cancer.
Filed under: Diagnosis, Management | Tagged: Diagnosis, imaging, research | 5 Comments »
In 2007 the voters of Texas approved state investment of $3 billion over 10 years to kick-start the Cancer Prevention and Research Institute of Texas or CPRIT. This will make CPRIT the third largest investor in cancer research after the National Institutes of Health and the American Cancer Society.
Filed under: Uncategorized | Tagged: CPRIT, Prevention, research, Texas | Leave a Comment »
Today’s news items include coverage of: A second report on BMI and pathologic outcomes in European patients Various research reports on early stage scientific developments A new, template-based form of prostate cancer biopsy technology
Filed under: Diagnosis, Drugs in development, Management, Treatment | Tagged: biopsy, BMI, outcomes, research, TargetScan | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site